NB
Nesli Basgoz
Director

Nesli Basgoz insider trades: Allergan (AGN) stock sales

Director, Allergan Last trade Aug 30, 2018 40 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2007
3
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Nesli reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 30, 2018AGN↓ Sell$201K
May 18, 2017AGN↓ Sell$416K
Dec 8, 2016AGN↓ Sell$94K
Aug 5, 2016AGN↓ Sell$192K
May 11, 2016AGN↓ Sell$103K
Dec 7, 2015AGN↓ Sell$720K
Jun 9, 2015ACT↓ Sell$655K
Mar 7, 2013FRX↓ Sell$457K
Jul 22, 2010FRX↓ Sell$28K
Mar 7, 2007FRX↓ Sell$181K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Nesli Basgoz's insider trades

Nesli Basgoz is a director at Allergan (AGN). Since Mar 7, 2007, Nesli has reported no open-market purchases and 10 sales worth $3.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (17 filings), shares withheld for taxes (10 filings), option exercises (8 filings), gifts (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.